Gene Therapy Market Research Report by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy, Suicide Gene Therapy, and Tumor Suppressor Gene Therapy), by Vector Type (Non-viral Vectors and Viral Vectors), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Gene Therapy Market is expected to grow from USD 2,314.78 Million in 2020 to USD 6,179.18 Million by the end of 2025.
2. The Global Gene Therapy Market is expected to grow from EUR 2,029.64 Million in 2020 to EUR 5,418.02 Million by the end of 2025.
3. The Global Gene Therapy Market is expected to grow from GBP 1,804.36 Million in 2020 to GBP 4,816.63 Million by the end of 2025.
4. The Global Gene Therapy Market is expected to grow from JPY 247,046.21 Million in 2020 to JPY 659,475.40 Million by the end of 2025.
5. The Global Gene Therapy Market is expected to grow from AUD 3,361.37 Million in 2020 to AUD 8,972.99 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Gene Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Gene Therapy Market studied across Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy, Suicide Gene Therapy, and Tumor Suppressor Gene Therapy.
Based on Vector Type, the Gene Therapy Market studied across Non-viral Vectors and Viral Vectors.
Based on Application, the Gene Therapy Market studied across Cardiovascular Diseases, Genetic Diseases, Infectious Diseases, Neurological Diseases, and Oncological Disorders.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Gene Therapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Gene Therapy Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Gene Therapy Market including Abeona Therapeutics, Inc.,, Achieve Life Sciences, Inc., Adaptimmune, AGTC, Akcea Therapeutics, Alnylam Pharmaceuticals, Inc., Amgen, Inc., AnGes, Inc., Audentes Therapeutics, Biogen, Bluebird bio, Inc., Dynavax Technologies, Editas Medicine, Gilead Sciences, Inc., Human Stem Cells Institute, Jazz Pharmaceuticals, Inc., Merck & Co., Inc, MolMed S.p.A., Novartis AG, Orchard Therapeutics plc., Sarepta Therapeutics, Inc., Sibiono GeneTech Co. Ltd., and Spark Therapeutics, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Gene Therapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Gene Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Gene Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Gene Therapy Market?
4. What is the competitive strategic window for opportunities in the Global Gene Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global Gene Therapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global Gene Therapy Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Gene Therapy Market is expected to grow from USD 2,314.78 Million in 2020 to USD 6,179.18 Million by the end of 2025.
2. The Global Gene Therapy Market is expected to grow from EUR 2,029.64 Million in 2020 to EUR 5,418.02 Million by the end of 2025.
3. The Global Gene Therapy Market is expected to grow from GBP 1,804.36 Million in 2020 to GBP 4,816.63 Million by the end of 2025.
4. The Global Gene Therapy Market is expected to grow from JPY 247,046.21 Million in 2020 to JPY 659,475.40 Million by the end of 2025.
5. The Global Gene Therapy Market is expected to grow from AUD 3,361.37 Million in 2020 to AUD 8,972.99 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Gene Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Gene Therapy Market studied across Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy, Suicide Gene Therapy, and Tumor Suppressor Gene Therapy.
Based on Vector Type, the Gene Therapy Market studied across Non-viral Vectors and Viral Vectors.
Based on Application, the Gene Therapy Market studied across Cardiovascular Diseases, Genetic Diseases, Infectious Diseases, Neurological Diseases, and Oncological Disorders.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Gene Therapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Gene Therapy Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Gene Therapy Market including Abeona Therapeutics, Inc.,, Achieve Life Sciences, Inc., Adaptimmune, AGTC, Akcea Therapeutics, Alnylam Pharmaceuticals, Inc., Amgen, Inc., AnGes, Inc., Audentes Therapeutics, Biogen, Bluebird bio, Inc., Dynavax Technologies, Editas Medicine, Gilead Sciences, Inc., Human Stem Cells Institute, Jazz Pharmaceuticals, Inc., Merck & Co., Inc, MolMed S.p.A., Novartis AG, Orchard Therapeutics plc., Sarepta Therapeutics, Inc., Sibiono GeneTech Co. Ltd., and Spark Therapeutics, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Gene Therapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Gene Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Gene Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Gene Therapy Market?
4. What is the competitive strategic window for opportunities in the Global Gene Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global Gene Therapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global Gene Therapy Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. Vector Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant way of treatment to eradicates the practice of surgery, drugs, or other procedures that lead to side effects on the health of individuals
5.1.1.2. Innovation in gene therapy for rare & cardiovascular diseases treatment coupled with the awareness regarding the ability of gene therapy
5.1.1.3. Application in the treatment of various diseases such as cancer, haemophilia, parkinson’s disease, and HIV
5.1.1.4. Government support and ethical acceptance of gene therapy for cancer treatment
5.1.2. Restraints
5.1.2.1. High cost associated with the gene therapies
5.1.3. Opportunities
5.1.3.1. Upsurge in a number of gene therapy treatment centers in developed countries
5.1.3.2. Increasing adoption for gene therapy for the oncological disorder
5.1.3.3. Growing strategic alliances and ongoing research for orphan diseases
5.1.4. Challenges
5.1.4.1. Potential disorders associated with the immune response
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL GENE THERAPY MARKET, BY TYPE
6.1. Introduction
6.2. Antigen Gene Therapy
6.3. Cancer Gene Therapy
6.4. Cytokine Gene Therapy
6.5. Suicide Gene Therapy
6.6. Tumor Suppressor Gene Therapy
7. GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE
7.1. Introduction
7.2. Non-viral Vectors
7.3. Viral Vectors
8. GLOBAL GENE THERAPY MARKET, BY APPLICATION
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Genetic Diseases
8.4. Infectious Diseases
8.5. Neurological Diseases
8.6. Oncological Disorders
9. AMERICAS GENE THERAPY MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC GENE THERAPY MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Abeona Therapeutics, Inc.,
13.2. Achieve Life Sciences, Inc.
13.3. Adaptimmune
13.4. AGTC
13.5. Akcea Therapeutics
13.6. Alnylam Pharmaceuticals, Inc.
13.7. Amgen, Inc.
13.8. AnGes, Inc.
13.9. Audentes Therapeutics
13.10. Biogen
13.11. Bluebird bio, Inc.
13.12. Dynavax Technologies
13.13. Editas Medicine
13.14. Gilead Sciences, Inc.
13.15. Human Stem Cells Institute
13.16. Jazz Pharmaceuticals, Inc.
13.17. Merck & Co., Inc
13.18. MolMed S.p.A.
13.19. Novartis AG
13.20. Orchard Therapeutics plc.
13.21. Sarepta Therapeutics, Inc.
13.22. Sibiono GeneTech Co. Ltd.
13.23. Spark Therapeutics, Inc.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. Vector Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant way of treatment to eradicates the practice of surgery, drugs, or other procedures that lead to side effects on the health of individuals
5.1.1.2. Innovation in gene therapy for rare & cardiovascular diseases treatment coupled with the awareness regarding the ability of gene therapy
5.1.1.3. Application in the treatment of various diseases such as cancer, haemophilia, parkinson’s disease, and HIV
5.1.1.4. Government support and ethical acceptance of gene therapy for cancer treatment
5.1.2. Restraints
5.1.2.1. High cost associated with the gene therapies
5.1.3. Opportunities
5.1.3.1. Upsurge in a number of gene therapy treatment centers in developed countries
5.1.3.2. Increasing adoption for gene therapy for the oncological disorder
5.1.3.3. Growing strategic alliances and ongoing research for orphan diseases
5.1.4. Challenges
5.1.4.1. Potential disorders associated with the immune response
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL GENE THERAPY MARKET, BY TYPE
6.1. Introduction
6.2. Antigen Gene Therapy
6.3. Cancer Gene Therapy
6.4. Cytokine Gene Therapy
6.5. Suicide Gene Therapy
6.6. Tumor Suppressor Gene Therapy
7. GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE
7.1. Introduction
7.2. Non-viral Vectors
7.3. Viral Vectors
8. GLOBAL GENE THERAPY MARKET, BY APPLICATION
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Genetic Diseases
8.4. Infectious Diseases
8.5. Neurological Diseases
8.6. Oncological Disorders
9. AMERICAS GENE THERAPY MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC GENE THERAPY MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Abeona Therapeutics, Inc.,
13.2. Achieve Life Sciences, Inc.
13.3. Adaptimmune
13.4. AGTC
13.5. Akcea Therapeutics
13.6. Alnylam Pharmaceuticals, Inc.
13.7. Amgen, Inc.
13.8. AnGes, Inc.
13.9. Audentes Therapeutics
13.10. Biogen
13.11. Bluebird bio, Inc.
13.12. Dynavax Technologies
13.13. Editas Medicine
13.14. Gilead Sciences, Inc.
13.15. Human Stem Cells Institute
13.16. Jazz Pharmaceuticals, Inc.
13.17. Merck & Co., Inc
13.18. MolMed S.p.A.
13.19. Novartis AG
13.20. Orchard Therapeutics plc.
13.21. Sarepta Therapeutics, Inc.
13.22. Sibiono GeneTech Co. Ltd.
13.23. Spark Therapeutics, Inc.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL GENE THERAPY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CANADA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CANADA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. MEXICO GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. MEXICO GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. UNITED STATES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED STATES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. AUSTRALIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. AUSTRALIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CHINA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CHINA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDONESIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDONESIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. JAPAN GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. JAPAN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MALAYSIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MALAYSIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. PHILIPPINES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. PHILIPPINES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH KOREA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH KOREA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. THAILAND GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. THAILAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. FRANCE GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. FRANCE GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GERMANY GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. GERMANY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. ITALY GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. ITALY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. NETHERLANDS GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. NETHERLANDS GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. QATAR GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. QATAR GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. RUSSIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. RUSSIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SPAIN GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SPAIN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. GLOBAL GENE THERAPY MARKET: SCORES
TABLE 107. GLOBAL GENE THERAPY MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL GENE THERAPY MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL GENE THERAPY MARKET: RANKING
TABLE 110. GLOBAL GENE THERAPY MARKET: MERGER & ACQUISITION
TABLE 111. GLOBAL GENE THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 112. GLOBAL GENE THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 113. GLOBAL GENE THERAPY MARKET: INVESTMENT & FUNDING
TABLE 114. GLOBAL GENE THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 115. GLOBAL GENE THERAPY MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL GENE THERAPY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CANADA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CANADA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. MEXICO GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. MEXICO GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. UNITED STATES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED STATES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. AUSTRALIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. AUSTRALIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CHINA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CHINA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDONESIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDONESIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. JAPAN GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. JAPAN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MALAYSIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MALAYSIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. PHILIPPINES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. PHILIPPINES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH KOREA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH KOREA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. THAILAND GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. THAILAND GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. FRANCE GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. FRANCE GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GERMANY GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. GERMANY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. ITALY GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. ITALY GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. NETHERLANDS GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. NETHERLANDS GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. QATAR GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. QATAR GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. RUSSIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. RUSSIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SPAIN GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SPAIN GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. GLOBAL GENE THERAPY MARKET: SCORES
TABLE 107. GLOBAL GENE THERAPY MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL GENE THERAPY MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL GENE THERAPY MARKET: RANKING
TABLE 110. GLOBAL GENE THERAPY MARKET: MERGER & ACQUISITION
TABLE 111. GLOBAL GENE THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 112. GLOBAL GENE THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 113. GLOBAL GENE THERAPY MARKET: INVESTMENT & FUNDING
TABLE 114. GLOBAL GENE THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 115. GLOBAL GENE THERAPY MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL GENE THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL GENE THERAPY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL GENE THERAPY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2020 (USD MILLION)
FIGURE 7. GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL GENE THERAPY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL GENE THERAPY MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL GENE THERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2020 VS 2025 (%)
FIGURE 23. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2025
FIGURE 25. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 28. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2025
FIGURE 30. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, 2020 VS 2025 (USD MILLION)
FIGURE 35. AMERICAS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. AMERICAS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. ARGENTINA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. BRAZIL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. CANADA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. MEXICO GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. UNITED STATES GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 44. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 46. AUSTRALIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. CHINA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. INDIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. INDONESIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. JAPAN GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. MALAYSIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. PHILIPPINES GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SOUTH KOREA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. THAILAND GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 58. FRANCE GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. GERMANY GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ITALY GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. NETHERLANDS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. QATAR GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. RUSSIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. SPAIN GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. GLOBAL GENE THERAPY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL GENE THERAPY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 71. GLOBAL GENE THERAPY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL GENE THERAPY MARKET, BY TYPE
FIGURE 1. GLOBAL GENE THERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL GENE THERAPY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL GENE THERAPY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2020 (USD MILLION)
FIGURE 7. GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL GENE THERAPY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL GENE THERAPY MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL GENE THERAPY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL GENE THERAPY MARKET SIZE, BY ANTIGEN GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL GENE THERAPY MARKET SIZE, BY CANCER GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL GENE THERAPY MARKET SIZE, BY CYTOKINE GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL GENE THERAPY MARKET SIZE, BY SUICIDE GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL GENE THERAPY MARKET SIZE, BY TUMOR SUPPRESSOR GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2020 VS 2025 (%)
FIGURE 23. GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY VECTOR TYPE, 2025
FIGURE 25. GLOBAL GENE THERAPY MARKET SIZE, BY NON-VIRAL VECTORS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL GENE THERAPY MARKET SIZE, BY VIRAL VECTORS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 28. GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GENE THERAPY MARKET SIZE, BY APPLICATION, 2025
FIGURE 30. GLOBAL GENE THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL GENE THERAPY MARKET SIZE, BY GENETIC DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL GENE THERAPY MARKET SIZE, BY INFECTIOUS DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL GENE THERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL GENE THERAPY MARKET SIZE, BY ONCOLOGICAL DISORDERS, 2020 VS 2025 (USD MILLION)
FIGURE 35. AMERICAS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. AMERICAS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. ARGENTINA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. BRAZIL GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. CANADA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. MEXICO GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. UNITED STATES GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 44. ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 46. AUSTRALIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. CHINA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. INDIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. INDONESIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. JAPAN GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. MALAYSIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. PHILIPPINES GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SOUTH KOREA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. THAILAND GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 58. FRANCE GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. GERMANY GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ITALY GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. NETHERLANDS GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. QATAR GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. RUSSIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SAUDI ARABIA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SOUTH AFRICA GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. SPAIN GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. UNITED KINGDOM GENE THERAPY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. GLOBAL GENE THERAPY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL GENE THERAPY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 71. GLOBAL GENE THERAPY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL GENE THERAPY MARKET, BY TYPE
